<DOC>
	<DOCNO>NCT00133341</DOCNO>
	<brief_summary>It purpose study determine concentration 3 allergen ( goldnatriumthiosulphate , methyldibromoglutharonitrile [ MDBGN ] , parthenolide ) diagnose allergic contact dermatitis .</brief_summary>
	<brief_title>Clinical Evaluation 3 Allergens : Methyldibromoglutharonitrile , Parthenolide Goldnatriumthiosulphate</brief_title>
	<detailed_description>The TRUE Test standard panel consist two tape strip , panel 1 11 allergen patch negative control panel 2 , 12 allergen patch . TRUE test panel 1 2 contain 23 frequent contact allergens.With 23 allergen , possible detect 60-70 % contact allergic reaction . Thus , need expand number allergen include TRUE Test order detect contact allergic reaction . Therefore goldnatriumthiosulphate , methyldibromoglutharonitrile parthenolide develop inclusion third TRUE Test panel . This study dose-response study use 3 dilution series detect optimum concentration 3 allergen . A phase-III study perform afterwards establish efficacy safety three allergen .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Contact</mesh_term>
	<mesh_term>Dermatitis , Allergic Contact</mesh_term>
	<mesh_term>Parthenolide</mesh_term>
	<criteria>Positive MDBGN patch test within late 5 year positive Parthenolide patch test within late 5 year positive Goldnatriumthiosulphate patch test within late 5 year . Age equal 18 year . Signed informed consent . Topical treatment corticosteroid immunosuppressives late 7 day test area near test area . Systemic treatment corticosteroid immunosuppressives late 7 day . Treatment UVlight late 3 week . Widespread active dermatitis dermatitis test area . Breastfeeding , pregnancy insufficient contraception . If doubt negative urinepregnancy test demonstrate patch test postpone one period . Subjects able cooperate . Participation clinical study study period 3 week prior study start .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2006</verification_date>
	<keyword>Allergic contact dermatitis , patch testing , dilution series</keyword>
</DOC>